About Us

Our Mission

Nocimed harnesses the existing power of Magnetic Resonance Spectroscopy (MRS) for non-invasive, objective quantification of relative chemical differences in tissues – but specifically applied to assess the relative chemical biomarkers for tissue degeneration and pain.

Nocimed was founded on the premise that when it comes to low back pain diagnosis and related patient management, there has to be a better way. By comparing differences in degenerative pain biomarkers between lumbar discs in patients receiving MRS exams of those tissues, this new information helps doctors to be better informed when they diagnose disc pathologies along the lumbar spine.

Nocimed is being positioned as a valuable resource to radiologists to enhance the value of lumbar MR exams, helping patients as well as referring physicians.

Who We Are

Founded in 2008 by co-inventors Dr. Jeff Lotz and Dr. David Bradford (both world renowned leaders in spine surgery and research from UCSF) and Jim Peacock (see below biographies), Nocimed was created to provide disruptive platform to help significantly improve pain diagnosis, initially focused on spine, using technologies originally invented at and exclusively licensed from UCSF. With the CE Marked NOCISCAN-LS disc MRS platform currently available for sale in select parts of Europe, Nocimed is quickly expanding to bring the non-invasive, pain-free, objectively quantitative lumbar pain diagnostic aid to more people – both in Europe and other parts of the world.

Our Management

Brett Lanuti

Common Director (Chief Executive Officer & President)

James Peacock III, Esq.

Founder & Board Chairman (VP Business Development & Legal Affairs)

Robert Eastlack, MD

Series A Preferred Director

Bill Wesemann

Series A Preferred Director

David K Neal

Series B Preferred Director

Sean Freeman

Series B Preferred Director (NuVasive Designee)

Lothar Koob

"Independent" Director (VP International & Radiology Services)

Jeffrey Lotz, PhD

Co-Founder & Co-Inventor; Chief Science Officer

John Claude, MS

VP, Engineering

NOCISCAN-LS™ Lumbar Spectroscopy Exam

A fast, revolutionary, cloud-based tool to help doctors diagnose Lumbar Back Pain

About Us

Nocimed harnesses the existing power of Magnetic Resonance Spectroscopy (MRS) for non-invasive, objective quantification of relative chemical differences in tissues applied to assess the relative chemical biomarkers for tissue degeneration and pain.

Nocimed™ , Inc.
370 Convention Way
Redwood City, CA 94063
Phone: (650) 241-1741
info@nocimed.com

Contact Us

Type the characters:captcha